{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T11:49:58Z","timestamp":1791805798508,"version":"4.3.4"},"reference-count":105,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental Cell Research"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1016\/j.yexcr.2012.02.027","type":"journal-article","created":{"date-parts":[[2012,3,7]],"date-time":"2012-03-07T10:08:54Z","timestamp":1331114934000},"page":"1040-1048","source":"Crossref","is-referenced-by-count":257,"title":["Role of FGF23 in vitamin D and phosphate metabolism: Implications in chronic kidney disease"],"prefix":"10.1016","volume":"318","author":[{"given":"L. Darryl","family":"Quarles","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yexcr.2012.02.027_bb0005","doi-asserted-by":"crossref","first-page":"3144","DOI":"10.1210\/jc.2006-0021","article-title":"Dietary phosphorus regulates serum fibroblast growth factor-23 concentrations in healthy men","volume":"91","author":"Antoniucci","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.yexcr.2012.02.027_bb0010","doi-asserted-by":"crossref","first-page":"5269","DOI":"10.1210\/en.2004-0233","article-title":"Transgenic mice overexpressing human fibroblast growth factor 23 (R176Q) delineate a putative role for parathyroid hormone in renal phosphate wasting disorders","volume":"145","author":"Bai","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.yexcr.2012.02.027_bb0015","doi-asserted-by":"crossref","first-page":"8465","DOI":"10.1021\/bi960658i","article-title":"Human 25-hydroxyvitamin D3-24-hydroxylase, a multicatalytic enzyme","volume":"35","author":"Beckman","year":"1996","journal-title":"Biochemistry"},{"key":"10.1016\/j.yexcr.2012.02.027_bb0020","first-page":"4003","article-title":"The parathyroid is a target organ for FGF23 in rats","volume":"117","author":"Ben-Dov","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.yexcr.2012.02.027_bb0025","first-page":"4003","article-title":"The parathyroid is a target organ for FGF23 in rats","volume":"117","author":"Ben-Dov","year":"2007","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.yexcr.2012.02.027_bb0030","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/hmg\/ddi034","article-title":"An FGF23 missense mutation causes familial tumoral calcinosis with hyperphosphatemia","volume":"14","author":"Benet-Pages","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.yexcr.2012.02.027_bb0035","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1097\/01.ASN.0000133041.27682.A2","article-title":"Mineral metabolism, mortality, and morbidity in maintenance hemodialysis","volume":"15","author":"Block","year":"2004","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.yexcr.2012.02.027_bb0040","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1210\/jc.2008-0220","article-title":"Hypophosphatemia with elevations in serum fibroblast growth factor 23 in a child with Jansen's metaphyseal chondrodysplasia","volume":"94","author":"Brown","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.yexcr.2012.02.027_bb0045","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1359\/jbmr.060507","article-title":"Regulation of C-terminal and intact FGF-23 by dietary phosphate in men and women","volume":"21","author":"Burnett","year":"2006","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.yexcr.2012.02.027_bb0050","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1002\/jbmr.321","article-title":"The osteoblast: an insulin target cell controlling glucose homeostasis","volume":"26","author":"Clemens","year":"2011","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.yexcr.2012.02.027_bb0055","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1093\/ndt\/gfl718","article-title":"Mineral metabolism parameters throughout chronic kidney disease stages 1\u20135\u2014achievement of K\/DOQI target ranges","volume":"22","author":"Craver","year":"2007","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.yexcr.2012.02.027_bb0060","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1038\/ng1905","article-title":"Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism","volume":"38","author":"Feng","year":"2006","journal-title":"Nat. Genet."},{"key":"10.1016\/j.yexcr.2012.02.027_bb0065","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1210\/jc.2004-1039","article-title":"Fibroblast growth factor-23 relationship to dietary phosphate and renal phosphate handling in healthy young men","volume":"90","author":"Ferrari","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.yexcr.2012.02.027_bb0070","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1681\/ASN.2006080936","article-title":"Fibroblast growth factor 23 (FGF23) predicts progression of chronic kidney disease: the Mild to Moderate Kidney Disease (MMKD) Study","volume":"18","author":"Fliser","year":"2007","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.yexcr.2012.02.027_bb0075","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/00041552-200207000-00003","article-title":"Fibroblast growth factor-23 is the phosphaturic factor in tumor-induced osteomalacia and may be phosphatonin","volume":"11","author":"Fukumoto","year":"2002","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"10.1016\/j.yexcr.2012.02.027_bb0080","doi-asserted-by":"crossref","unstructured":"Galitzer, H., Ben-Dov, I.Z., Silver, J., and Naveh-Many, T. Parathyroid cell resistance to fibroblast growth factor 23 in secondary hyperparathyroidism of chronic kidney disease. Kidney Int. 77: 211\u2013218.","DOI":"10.1038\/ki.2009.464"},{"key":"10.1016\/j.yexcr.2012.02.027_bb0085","doi-asserted-by":"crossref","DOI":"10.1002\/jor.20857","article-title":"FGF23 is a putative marker for bone healing and regeneration","author":"Goebel","year":"2009","journal-title":"J. Orthop. Res."},{"key":"10.1016\/j.yexcr.2012.02.027_bb0090","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1681\/ASN.2005010052","article-title":"Fibroblast growth factor-23 mitigates hyperphosphatemia but accentuates calcitriol deficiency in chronic kidney disease","volume":"16","author":"Gutierrez","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.yexcr.2012.02.027_bb0095","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJMoa0706130","article-title":"Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis","volume":"359","author":"Gutierrez","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.yexcr.2012.02.027_bb0100","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/ki.2010.313","article-title":"Direct evidence for a causative role of FGF23 in the abnormal renal phosphate handling and vitamin D metabolism in rats with early-stage chronic kidney disease","volume":"78","author":"Hasegawa","year":"2010","journal-title":"Kidney Int."},{"key":"10.1016\/j.yexcr.2012.02.027_bb0105","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/ki.2010.168","article-title":"Dysregulation of renal vitamin D metabolism in the uremic rat","volume":"78","author":"Helvig","year":"2010","journal-title":"Kidney Int."},{"key":"10.1016\/j.yexcr.2012.02.027_bb0110","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1073\/pnas.1005011108","article-title":"Parathyroid hormone\/parathyroid hormone-related protein receptor signaling is required for maintenance of the growth plate in postnatal life","volume":"108","author":"Hirai","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.yexcr.2012.02.027_bb0115","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1111\/j.1523-1755.2004.00402.x","article-title":"Regulation of gene expression by dietary Ca2+ in kidneys of 25-hydroxyvitamin D3-1 alpha-hydroxylase knockout mice","volume":"65","author":"Hoenderop","year":"2004","journal-title":"Kidney Int."},{"key":"10.1016\/j.yexcr.2012.02.027_bb0120","doi-asserted-by":"crossref","DOI":"10.1096\/fj.10-154765","article-title":"Klotho: a novel phosphaturic substance acting as an autocrine enzyme in the renal proximal tubule","author":"Hu","year":"2010","journal-title":"FASEB J."},{"key":"10.1016\/j.yexcr.2012.02.027_bb0125","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1111\/j.1523-1755.2004.00604.x","article-title":"FGF-23 in patients with end-stage renal disease on hemodialysis","volume":"65","author":"Imanishi","year":"2004","journal-title":"Kidney Int."},{"key":"10.1016\/j.yexcr.2012.02.027_bb0130","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1093\/ndt\/gfq419","article-title":"Pilot study of dietary phosphorus restriction and phosphorus binders to target fibroblast growth factor 23 in patients with chronic kidney disease","volume":"26","author":"Isakova","year":"2010","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.yexcr.2012.02.027_bb0135","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1093\/ndt\/gfn571","article-title":"Peripheral vascular calcification in long-haemodialysis patients: associated factors and survival consequences","volume":"24","author":"Jean","year":"2009","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.yexcr.2012.02.027_bb0140","doi-asserted-by":"crossref","first-page":"18370","DOI":"10.1074\/jbc.M602469200","article-title":"Polypeptide GalNAc-transferase T3 and familial tumoral calcinosis. Secretion of fibroblast growth factor 23 requires O-glycosylation","volume":"281","author":"Kato","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yexcr.2012.02.027_bb0145","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1681\/ASN.2006070783","article-title":"Parathyroid hormone regulates fibroblast growth factor-23 in a mouse model of primary hyperparathyroidism","volume":"18","author":"Kawata","year":"2007","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.yexcr.2012.02.027_bb0150","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1016\/j.lfs.2005.09.052","article-title":"Expression of FGF23 is correlated with serum phosphate level in isolated fibrous dysplasia","volume":"78","author":"Kobayashi","year":"2006","journal-title":"Life Sci."},{"key":"10.1016\/j.yexcr.2012.02.027_bb0155","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1530\/eje.1.02053","article-title":"Regulation of plasma fibroblast growth factor 23 by calcium in primary hyperparathyroidism","volume":"154","author":"Kobayashi","year":"2006","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.yexcr.2012.02.027_bb0160","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1006\/bbrc.2000.4226","article-title":"Severely reduced production of klotho in human chronic renal failure kidney","volume":"280","author":"Koh","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.yexcr.2012.02.027_bb0165","doi-asserted-by":"crossref","first-page":"G1036","DOI":"10.1152\/ajpgi.00243.2005","article-title":"1alpha,25-Dihydroxyvitamin D3 upregulates FGF23 gene expression in bone: the final link in a renal\u2013gastrointestinal\u2013skeletal axis that controls phosphate transport","volume":"289","author":"Kolek","year":"2005","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.yexcr.2012.02.027_bb0170","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/ki.2009.466","article-title":"FGF23-parathyroid interaction: implications in chronic kidney disease","volume":"77","author":"Komaba","year":"2010","journal-title":"Kidney Int."},{"key":"10.1016\/j.yexcr.2012.02.027_bb0175","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s00424-009-0722-7","article-title":"Klotho","volume":"459","author":"Kuro-o","year":"2010","journal-title":"Pflugers Arch."},{"key":"10.1016\/j.yexcr.2012.02.027_bb0180","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/36285","article-title":"Mutation of the mouse klotho gene leads to a syndrome resembling ageing","volume":"390","author":"Kuro-o","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.yexcr.2012.02.027_bb0185","doi-asserted-by":"crossref","first-page":"6120","DOI":"10.1074\/jbc.C500457200","article-title":"Regulation of fibroblast growth factor-23 signaling by klotho","volume":"281","author":"Kurosu","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yexcr.2012.02.027_bb0190","doi-asserted-by":"crossref","first-page":"3883","DOI":"10.1210\/en.2005-0431","article-title":"Fibroblast growth factor-23 mutants causing familial tumoral calcinosis are differentially processed","volume":"146","author":"Larsson","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.yexcr.2012.02.027_bb0195","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1210\/en.2003-1768","article-title":"Transgenic mice expressing fibroblast growth factor 23 under the control of the alpha1(I) collagen promoter exhibit growth retardation, osteomalacia, and disturbed phosphate homeostasis","volume":"145","author":"Larsson","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/j.yexcr.2012.02.027_bb0200","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1046\/j.1523-1755.2003.00328.x","article-title":"Circulating concentration of FGF-23 increases as renal function declines in patients with chronic kidney disease, but does not change in response to variation in phosphate intake in healthy volunteers","volume":"64","author":"Larsson","year":"2003","journal-title":"Kidney Int."},{"key":"10.1016\/j.yexcr.2012.02.027_bb0205","doi-asserted-by":"crossref","first-page":"F882","DOI":"10.1152\/ajprenal.00360.2010","article-title":"PTH increases FGF23 gene expression and mediates the high-FGF23 levels of experimental kidney failure: a bone parathyroid feedback loop","volume":"299","author":"Lavi-Moshayoff","year":"2010","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.yexcr.2012.02.027_bb0210","doi-asserted-by":"crossref","first-page":"E508","DOI":"10.1152\/ajpendo.00499.2010","article-title":"Compound deletion of Fgfr3 and Fgfr4 partially rescues the Hyp mouse phenotype","volume":"300","author":"Li","year":"2011","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.yexcr.2012.02.027_bb0215","first-page":"E508","article-title":"Compound deletion of FGFR3 and FGFR4 partially rescues the Hyp mouse phenotype","author":"Li","year":"2010","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.yexcr.2012.02.027_bb0220","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1247\/csf.29.91","article-title":"Immunohistochemical localization of Klotho protein in brain, kidney, and reproductive organs of mice","volume":"29","author":"Li","year":"2004","journal-title":"Cell Struct. Funct."},{"key":"10.1016\/j.yexcr.2012.02.027_bb0225","doi-asserted-by":"crossref","first-page":"37419","DOI":"10.1074\/jbc.M304544200","article-title":"Regulation of fibroblastic growth factor 23 expression but not degradation by PHEX","volume":"278","author":"Liu","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yexcr.2012.02.027_bb0230","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1681\/ASN.2007010068","article-title":"How fibroblast growth factor 23 works","volume":"18","author":"Liu","year":"2007","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.yexcr.2012.02.027_bb0235","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1677\/joe.1.07059","article-title":"Phosphorylated acidic serine-aspartate-rich MEPE-associated motif peptide from matrix extracellular phosphoglycoprotein inhibits phosphate regulating gene with homologies to endopeptidases on the X-chromosome enzyme activity","volume":"192","author":"Liu","year":"2007","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.yexcr.2012.02.027_bb0240","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1210\/me.2009-0085","article-title":"Novel regulators of Fgf23 expression and mineralization in Hyp bone","volume":"23","author":"Liu","year":"2009","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.yexcr.2012.02.027_bb0245","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1681\/ASN.2005111185","article-title":"Fibroblast growth factor 23 is a counter-regulatory phosphaturic hormone for vitamin D","volume":"17","author":"Liu","year":"2006","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.yexcr.2012.02.027_bb0250","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1681\/ASN.2007121301","article-title":"FGFR3 and FGFR4 do not mediate renal effects of FGF23","volume":"19","author":"Liu","year":"2008","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.yexcr.2012.02.027_bb0255","doi-asserted-by":"crossref","first-page":"E38","DOI":"10.1152\/ajpendo.00008.2006","article-title":"Pathogenic role of Fgf23 in Hyp mice","volume":"291","author":"Liu","year":"2006","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.yexcr.2012.02.027_bb0260","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.bone.2004.06.014","article-title":"Bone as a source of FGF23: regulation by phosphate?","volume":"35","author":"Mirams","year":"2004","journal-title":"Bone"},{"key":"10.1016\/j.yexcr.2012.02.027_bb0265","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1161\/ATVBAHA.110.214619","article-title":"Circulating fibroblast growth factor-23 is associated with fat mass and dyslipidemia in two independent cohorts of elderly individuals","volume":"31","author":"Mirza","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.yexcr.2012.02.027_bb0270","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1038\/sj.ki.5000414","article-title":"Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO)","volume":"69","author":"Moe","year":"2006","journal-title":"Kidney Int."},{"key":"10.1016\/j.yexcr.2012.02.027_bb0275","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2215\/CJN.05040610","article-title":"Vegetarian compared with meat dietary protein source and phosphorus homeostasis in chronic kidney disease","volume":"6","author":"Moe","year":"2010","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.yexcr.2012.02.027_bb0280","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/sj.ki.5000020","article-title":"Effect of manipulating serum phosphorus with phosphate binder on circulating PTH and FGF23 in renal failure rats","volume":"69","author":"Nagano","year":"2006","journal-title":"Kidney Int."},{"key":"10.1016\/j.yexcr.2012.02.027_bb0285","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1038\/sj.ki.5002000","article-title":"Acute effect of oral phosphate loading on serum fibroblast growth factor 23 levels in healthy men","volume":"70","author":"Nishida","year":"2006","journal-title":"Kidney Int."},{"key":"10.1016\/j.yexcr.2012.02.027_bb0290","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1038\/ki.2010.334","article-title":"Recent progress in the treatment of vascular calcification","volume":"78","author":"O'Neill","year":"2010","journal-title":"Kidney Int."},{"key":"10.1016\/j.yexcr.2012.02.027_bb0295","doi-asserted-by":"crossref","first-page":"286","DOI":"10.2215\/CJN.05420709","article-title":"Early control of PTH and FGF23 in normophosphatemic CKD patients: a new target in CKD-MBD therapy?","volume":"5","author":"Oliveira","year":"2010","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.yexcr.2012.02.027_bb0300","doi-asserted-by":"crossref","first-page":"5358","DOI":"10.1210\/en.2005-0777","article-title":"Dietary and serum phosphorus regulate fibroblast growth factor 23 expression and 1,25-dihydroxyvitamin D metabolism in mice","volume":"146","author":"Perwad","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.yexcr.2012.02.027_bb0305","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/nm0411-428","article-title":"The bone and beyond: \u2018dem bones\u2019 are made for more than walking","volume":"17","author":"Quarles","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.yexcr.2012.02.027_bb0310","doi-asserted-by":"crossref","first-page":"3820","DOI":"10.1172\/JCI36479","article-title":"Endocrine functions of bone in mineral metabolism regulation","volume":"118","author":"Quarles","year":"2008","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.yexcr.2012.02.027_bb0315","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1172\/JCI200319687","article-title":"Evidence for a bone-kidney axis regulating phosphate homeostasis","volume":"112","author":"Quarles","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.yexcr.2012.02.027_bb0320","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1210\/en.131.1.122","article-title":"Effects of etidronate-mediated suppression of bone remodeling on aluminum-induced de novo bone formation","volume":"131","author":"Quarles","year":"1992","journal-title":"Endocrinology"},{"key":"10.1016\/j.yexcr.2012.02.027_bb0325","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1093\/ndt\/gfh991","article-title":"FGF-23, vitamin D and calcification: the unholy triad","volume":"20","author":"Razzaque","year":"2005","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.yexcr.2012.02.027_bb0330","first-page":"A09001860","article-title":"FGF23 gene expression is upregulated by PTH receptor activation in osteocytes in vitr and in vivo: a parathyroid-bone link influencing the endocrine function of osteocytes","author":"Rhee","year":"2009"},{"key":"10.1016\/j.yexcr.2012.02.027_bb0335","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1002\/jbmr.304","article-title":"PTH receptor signaling in osteocytes governs periosteal bone formation and intra-cortical remodeling","volume":"26","author":"Rhee","year":"2010","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.yexcr.2012.02.027_bb0340","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.bone.2011.06.025","article-title":"Parathyroid hormone receptor signaling in osteocytes increases the expression of fibroblast growth factor-23 in vitro and in vivo","volume":"49","author":"Rhee","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.yexcr.2012.02.027_bb0345","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1172\/JCI18399","article-title":"FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting","volume":"112","author":"Riminucci","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.yexcr.2012.02.027_bb0350","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1056\/NEJMcp1009570","article-title":"Clinical practice. Vitamin D insufficiency","volume":"364","author":"Rosen","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.yexcr.2012.02.027_bb0355","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.bone.2003.10.005","article-title":"MEPE has the properties of an osteoblastic phosphatonin and minhibin","volume":"34","author":"Rowe","year":"2004","journal-title":"Bone"},{"key":"10.1016\/j.yexcr.2012.02.027_bb0360","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1074\/jbc.M408903200","article-title":"Circulating FGF-23 is regulated by 1alpha,25-dihydroxyvitamin D3 and phosphorus in vivo","volume":"280","author":"Saito","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.yexcr.2012.02.027_bb0365","doi-asserted-by":"crossref","first-page":"F1212","DOI":"10.1152\/ajprenal.00169.2010","article-title":"Fibroblast growth factor 23 production in bone is directly regulated by 1{alpha},25-dihydroxyvitamin D, but not PTH","volume":"299","author":"Saji","year":"2010","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.yexcr.2012.02.027_bb0370","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1159\/000210389","article-title":"Regulation of fibroblast growth factor 23 production in bone in uremic rats","volume":"111","author":"Saji","year":"2009","journal-title":"Nephron Physiol."},{"key":"10.1016\/j.yexcr.2012.02.027_bb0375","doi-asserted-by":"crossref","first-page":"4835","DOI":"10.1210\/en.2009-0472","article-title":"Bone formation regulates circulating concentrations of fibroblast growth factor 23","volume":"150","author":"Samadfam","year":"2009","journal-title":"Endocrinology"},{"key":"10.1016\/j.yexcr.2012.02.027_bb0380","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0272-6386(04)00817-0","article-title":"Total parathyroidectomy reduces elevated circulating fibroblast growth factor 23 in advanced secondary hyperparathyroidism","volume":"44","author":"Sato","year":"2004","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.yexcr.2012.02.027_bb0385","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1172\/JCI200419081","article-title":"Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism","volume":"113","author":"Shimada","year":"2004","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.yexcr.2012.02.027_bb0390","doi-asserted-by":"crossref","first-page":"6500","DOI":"10.1073\/pnas.101545198","article-title":"Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia","volume":"98","author":"Shimada","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.yexcr.2012.02.027_bb0395","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1161\/01.CIR.0000139854.74847.99","article-title":"Angiogenesis and vasculogenesis are impaired in the precocious-aging klotho mouse","volume":"110","author":"Shimada","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.yexcr.2012.02.027_bb0400","doi-asserted-by":"crossref","first-page":"F1088","DOI":"10.1152\/ajprenal.00474.2004","article-title":"Vitamin D receptor-independent FGF23 actions in regulating phosphate and vitamin D metabolism","volume":"289","author":"Shimada","year":"2005","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.yexcr.2012.02.027_bb0405","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1056\/NEJMoa011262","article-title":"Paternally inherited inactivating mutations of the GNAS1 gene in progressive osseous heteroplasia","volume":"346","author":"Shore","year":"2002","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.yexcr.2012.02.027_bb0410","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.matbio.2004.09.007","article-title":"Homozygous ablation of fibroblast growth factor-23 results in hyperphosphatemia and impaired skeletogenesis, and reverses hypophosphatemia in Phex-deficient mice","volume":"23","author":"Sitara","year":"2004","journal-title":"Matrix Biol."},{"key":"10.1016\/j.yexcr.2012.02.027_bb0415","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.2353\/ajpath.2006.060329","article-title":"Genetic ablation of vitamin D activation pathway reverses biochemical and skeletal anomalies in Fgf-23-null animals","volume":"169","author":"Sitara","year":"2006","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.yexcr.2012.02.027_bb0420","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/j.1525-139X.2007.00308.x","article-title":"Role of fibroblast growth factor 23 in phosphate homeostasis and pathogenesis of disordered mineral metabolism in chronic kidney disease","volume":"20","author":"Stubbs","year":"2007","journal-title":"Semin. Dial."},{"key":"10.1016\/j.yexcr.2012.02.027_bb0425","article-title":"Cholecalciferol supplementation alters calcitriol-responsive monocyte proteins and decreases inflammatory cytokines in ESRD","author":"Stubbs","year":"2009","journal-title":"J. Am. Soc. Nephrol."},{"issue":"33\u201334","key":"10.1016\/j.yexcr.2012.02.027_bb0430","first-page":"36","article-title":"Fibroblast growth factor 23: uremic toxin or innocent bystander in chronic kidney disease?","volume":"23","author":"Stubbs","year":"2009","journal-title":"Nephrol. News Issues"},{"key":"10.1016\/j.yexcr.2012.02.027_bb0435","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1161\/01.CIR.0000124224.48962.32","article-title":"Sinoatrial node dysfunction and early unexpected death of mice with a defect of klotho gene expression","volume":"109","author":"Takeshita","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.yexcr.2012.02.027_bb0440","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.4065\/79.12.1508","article-title":"Fibroblast growth factor 23, parathyroid hormone, and 1alpha,25-dihydroxyvitamin D in surgically treated primary hyperparathyroidism","volume":"79","author":"Tebben","year":"2004","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.yexcr.2012.02.027_bb0445","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1038\/sj.ki.5001868","article-title":"Mortality risk among hemodialysis patients receiving different vitamin D analogs","volume":"70","author":"Tentori","year":"2006","journal-title":"Kidney Int."},{"key":"10.1016\/j.yexcr.2012.02.027_bb0450","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1073\/pnas.0913986107","article-title":"Relevant use of Klotho in FGF19 subfamily signaling system in vivo","volume":"107","author":"Tomiyama","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.yexcr.2012.02.027_bb0455","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1002\/jbmr.65","article-title":"Leptin stimulates fibroblast growth factor 23 expression in bone and suppresses renal 1alpha,25-dihydroxyvitamin D(3) synthesis in leptin-deficient ob\/ob mice","volume":"25","author":"Tsuji","year":"2010","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.yexcr.2012.02.027_bb0460","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/nature05315","article-title":"Klotho converts canonical FGF receptor into a specific receptor for FGF23","volume":"444","author":"Urakawa","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.yexcr.2012.02.027_bb0465","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1530\/EJE-10-0591","article-title":"Effects of vitamin D replacement therapy on serum FGF23 concentrations in vitamin D-deficient women in short term","volume":"163","author":"Uzum","year":"2010","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.yexcr.2012.02.027_bb0470","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jsbmb.2004.03.029","article-title":"Regulation of the epithelial Ca2+ channels TRPV5 and TRPV6 by 1alpha,25-dihydroxy Vitamin D3 and dietary Ca2+","volume":"89\u201390","author":"van de Graaf","year":"2004","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.yexcr.2012.02.027_bb0475","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/ki.2010.107","article-title":"Fibroblast growth factor 23 and bone metabolism in children with chronic kidney disease","volume":"78","author":"van Husen","year":"2010","journal-title":"Kidney Int."},{"key":"10.1016\/j.yexcr.2012.02.027_bb0480","article-title":"Effects of dietary phosphate and calcium intake on Fibroblast Growth Factor-23","author":"Vervloet","year":"2010","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.yexcr.2012.02.027_bb0485","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1359\/jbmr.2003.18.7.1227","article-title":"Serum FGF23 levels in normal and disordered phosphorus homeostasis","volume":"18","author":"Weber","year":"2003","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.yexcr.2012.02.027_bb0490","article-title":"Effects of cinacalcet and concurrent low-dose vitamin D on FGF23 levels in ESRD","author":"Wetmore","year":"2009","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.yexcr.2012.02.027_bb0495","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/ncpneph0977","article-title":"Calcimimetics or vitamin D analogs for suppressing parathyroid hormone in end-stage renal disease: time for a paradigm shift?","volume":"5","author":"Wetmore","year":"2009","journal-title":"Nat. Clin. Pract. Nephrol."},{"key":"10.1016\/j.yexcr.2012.02.027_bb0500","doi-asserted-by":"crossref","first-page":"E57","DOI":"10.1210\/jc.2010-1277","article-title":"Elevated FGF23 levels are associated with impaired calcium-mediated suppression of PTH in ESRD","volume":"96","author":"Wetmore","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.yexcr.2012.02.027_bb0505","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1046\/j.1523-1755.2001.00064.x","article-title":"Autosomal-dominant hypophosphatemic rickets (ADHR) mutations stabilize FGF-23","volume":"60","author":"White","year":"2001","journal-title":"Kidney Int."},{"key":"10.1016\/j.yexcr.2012.02.027_bb0510","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1681\/ASN.2009121293","article-title":"Forging forward with 10 burning questions on FGF23 in kidney disease","volume":"21","author":"Wolf","year":"2010","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.yexcr.2012.02.027_bb0515","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1006\/bbrc.2000.3696","article-title":"Identification of a novel fibroblast growth factor, FGF-23, preferentially expressed in the ventrolateral thalamic nucleus of the brain","volume":"277","author":"Yamashita","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.yexcr.2012.02.027_bb0520","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0272-6386(04)01103-5","article-title":"Magnitude and impact of abnormal mineral metabolism in hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS)","volume":"44","author":"Young","year":"2004","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.yexcr.2012.02.027_bb0525","doi-asserted-by":"crossref","first-page":"4647","DOI":"10.1210\/en.2005-0670","article-title":"Analysis of the biochemical mechanisms for the endocrine actions of Fibroblast Growth Factor-23","volume":"146","author":"Yu","year":"2005","journal-title":"Endocrinology"}],"container-title":["Experimental Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482712001036?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482712001036?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,24]],"date-time":"2019-06-24T21:44:47Z","timestamp":1561412687000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014482712001036"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":105,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["S0014482712001036"],"URL":"https:\/\/doi.org\/10.1016\/j.yexcr.2012.02.027","relation":{},"ISSN":["0014-4827"],"issn-type":[{"value":"0014-4827","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]}}}